| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |